The largest database of trusted experimental protocols

5 protocols using sk mel 5 cells

1

Cell Culture Conditions for Melanoma and Fibroblast

Check if the same lab product or an alternative is used in the 5 most similar protocols
The A375 human malignant melanoma cell line (ATCC, cat. no. CRL-1619) was cultured in Dulbecco’s Modified Eagle Medium (DMEM) (cat. no. 10–013-CV, Corning) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (cat. no. FP-0500-A, Atlas Biologicals, Fort Collins, CO, USA), 1% Minimum Essential Medium (MEM) Non-Essential Amino Acids (cat. no. 11140–050, Gibco), 1% L- glutamine (cat. no. 25–005-CI, Corning) and 1 mM β-mercaptoethanol. Human malignant melanoma SK-MEL-5 cells (ATCC, cat. no. HTB-70) were cultured in MEM (cat. no. 10–010-CV, Corning) supplemented with 10% (v/v) heat-inactivated FBS. Human primary dermal fibroblasts (cat. no. PCS-201–012) were purchased from American Type Culture Collection and maintained in Fibroblast Basal Medium (cat. no. CS- 201–030, ATCC) supplemented with Fibroblast Growth Kit-Low serum (cat. no. PCS-201–041, ATCC) according to manufacturer recommendations. All cell lines were maintained at 37 °C with 5% CO2. A375 and SK-MEL-5 cell lines were reported negative for mycoplasma contamination in February 2022 and validated as authentic, giving a 100% match when compared to the known reference profile through short tandem repeat profiling performed by Genetica DNA Laboratories (Burlington, NC, USA) [22 (link)].
+ Open protocol
+ Expand
2

Cell Culture Conditions for Melanoma and Fibroblast

Check if the same lab product or an alternative is used in the 5 most similar protocols
The A375 human malignant melanoma cell line (ATCC, cat. no. CRL-1619) was cultured in Dulbecco’s Modified Eagle Medium (DMEM) (cat. no. 10–013-CV, Corning) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (cat. no. FP-0500-A, Atlas Biologicals, Fort Collins, CO, USA), 1% Minimum Essential Medium (MEM) Non-Essential Amino Acids (cat. no. 11140–050, Gibco), 1% L- glutamine (cat. no. 25–005-CI, Corning) and 1 mM β-mercaptoethanol. Human malignant melanoma SK-MEL-5 cells (ATCC, cat. no. HTB-70) were cultured in MEM (cat. no. 10–010-CV, Corning) supplemented with 10% (v/v) heat-inactivated FBS. Human primary dermal fibroblasts (cat. no. PCS-201–012) were purchased from American Type Culture Collection and maintained in Fibroblast Basal Medium (cat. no. CS- 201–030, ATCC) supplemented with Fibroblast Growth Kit-Low serum (cat. no. PCS-201–041, ATCC) according to manufacturer recommendations. All cell lines were maintained at 37 °C with 5% CO2. A375 and SK-MEL-5 cell lines were reported negative for mycoplasma contamination in February 2022 and validated as authentic, giving a 100% match when compared to the known reference profile through short tandem repeat profiling performed by Genetica DNA Laboratories (Burlington, NC, USA) [22 (link)].
+ Open protocol
+ Expand
3

Culturing Human Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer MCF-7 cells, human lung cancer A549 cells and human skin cancer SK-MEL-5 cells were procured from American Type Culture Collection. The cells were cultured under sterile conditions at 37˚C in a humid environment containing CO2 (5%) and the culture medium comprised DMEM or RPMI 1640 medium supplemented with FBS (10%), glutamine (4 mM), penicillin (100 U/ml) and streptomycin (100 µg/ml). The cultures were regularly checked and trypsinised when the cell confluence reached 85%.
+ Open protocol
+ Expand
4

Cell Culture and LD Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
A375 cells were purchased from the Cell Bank of the Committee on Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). B16F0 cells were obtained from the China Center for Type Culture Collection (Wuhan, China). SK-MEL-5 cells were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA). A375 cells were cultured in Gibco™ DMEM, while SK-MEL-5 and B16F0 cells were cultured in Gibco™ RPMI-1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing HyClone™ 10% fetal bovine serum (FBS; GE Healthcare Life Sciences), 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. All cell lines were cultured at 37°C in 5% CO2. Cells were allowed to attach for 24 h before treatment. LD was dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) and diluted with fresh medium to achieve the desired concentration. The final concentration of DMSO did not exceed 0.2% in the fresh medium, and DMSO at this concentration has no significant effect on cell viability.
+ Open protocol
+ Expand
5

Cytotoxicity Evaluation of Test Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human malignant melanoma SKMEL-5 cells were obtained from the American
Type Culture Collection (ATCC HTB-70, Manassas, VA, USA) and were
maintained in 5% CO2 at 37 °C and cultured in Eagle’s
Minimum Essential Medium (EMEM; Cellgro) plus GlutaMAX supplemented
with 10% fetal bovine serum (FBS; Omega Scientific) and 1% penicillin/streptomycin
(Omega Scientific).
Approximately 30 000 cells were seeded
into individual wells of a 96-well tissue culture plate and incubated
for 24 h. Cells were replenished with fresh medium (0.1 mL/well; 5%
FBS, no antibiotics) and exposed to triplicates of different concentration
solutions (from 0.4 to 100 μM) of test compounds. The analyzed
inhibitors were dissolved in DMSO, reaching a final DMSO concentration
of 1%. After incubation for 24 h at 37 °C and 5% CO2, cell viability was assessed using ATPlite assay from PerkinElmer
(Waltham, MA). Viability was normalized to control cells which were
treated with the vehicle, DMSO. The reported IC50 values
were calculated by Prism5 (GraphPad).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!